BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34369323)

  • 1. Expert consensus statement on acute hepatic porphyria in Belgium.
    Gilles A; Vermeersch S; Vermeersch P; Wolff F; Cotton F; Tilleux S; Cassiman D
    Acta Clin Belg; 2022 Aug; 77(4):735-741. PubMed ID: 34369323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
    Wang B; Bonkovsky HL; Lim JK; Balwani M
    Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PICO questions and DELPHI methodology for improving the management of patients with acute hepatic porphyria.
    Riera-Mestre A; García Morillo JS; Castelbón Fernández J; Hernández-Contreras ME; Aguilera Peiró P; Jacob J; Martínez Valle F; Guillén-Navarro E; Morales-Conejo M
    Rev Clin Esp (Barc); 2024 May; 224(5):272-280. PubMed ID: 38642893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
    Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagström H; Sardh E; Wahlin S
    J Intern Med; 2022 Jun; 291(6):824-836. PubMed ID: 35112415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human hereditary hepatic porphyrias.
    Nordmann Y; Puy H
    Clin Chim Acta; 2002 Nov; 325(1-2):17-37. PubMed ID: 12367763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).
    Bonkovsky HL; Dixon N; Rudnick S
    Mol Genet Metab; 2019 Nov; 128(3):213-218. PubMed ID: 30987916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study.
    Horie Y; Yasuoka Y; Adachi T
    Orphanet J Rare Dis; 2023 Dec; 18(1):384. PubMed ID: 38066651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hepatic porphyrias: Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations.
    Loskove Y; Yasuda M; Chen B; Nazarenko I; Cody N; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):352-357. PubMed ID: 30385147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.
    Yasuda M; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):332-341. PubMed ID: 30737139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of inherited porphyrias in Europe.
    Elder G; Harper P; Badminton M; Sandberg S; Deybach JC
    J Inherit Metab Dis; 2013 Sep; 36(5):849-57. PubMed ID: 23114748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute porphyrias - A neurological perspective.
    Gerischer LM; Scheibe F; Nümann A; Köhnlein M; Stölzel U; Meisel A
    Brain Behav; 2021 Nov; 11(11):e2389. PubMed ID: 34661997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword.
    Peoc'h K; Manceau H; Karim Z; Wahlin S; Gouya L; Puy H; Deybach JC
    Mol Genet Metab; 2019 Nov; 128(3):236-241. PubMed ID: 30413387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Porphyrias.
    Besur S; Schmeltzer P; Bonkovsky HL
    J Emerg Med; 2015 Sep; 49(3):305-12. PubMed ID: 26159905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.
    Marcacci M; Ricci A; Cuoghi C; Marchini S; Pietrangelo A; Ventura P
    Orphanet J Rare Dis; 2022 Apr; 17(1):160. PubMed ID: 35392955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic porphyria: A narrative review.
    Arora S; Young S; Kodali S; Singal AK
    Indian J Gastroenterol; 2016 Nov; 35(6):405-418. PubMed ID: 27796941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of diagnostic algorithms for the laboratory diagnosis of porphyrias.
    Lefever S; Peersman N; Meersseman W; Cassiman D; Vermeersch P
    J Inherit Metab Dis; 2022 Nov; 45(6):1151-1162. PubMed ID: 36053909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life Impacts.
    Wheeden K; Lyon Howe D; Burrell S; Gill L; Chamberlayne J; Williams ER; Simon A; Ko JJ; Mora J; Wells T; Evans C; Paulich M; Meninger S; Lombardelli S
    Adv Ther; 2022 Sep; 39(9):4330-4345. PubMed ID: 35907153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.
    Cohen AM; Chamberlin S; Deloughery T; Nguyen M; Bedrick S; Meninger S; Ko JJ; Amin JJ; Wei AJ; Hersh W
    PLoS One; 2020; 15(7):e0235574. PubMed ID: 32614911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic porphyrias in children.
    Elder GH
    J Inherit Metab Dis; 1997 Jun; 20(2):237-46. PubMed ID: 9211196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aminolevulinate dehydratase porphyria: Update on hepatic 5-aminolevulinic acid synthase induction and long-term response to hemin.
    Lahiji AP; Anderson KE; Chan A; Simon A; Desnick RJ; Ramanujam VMS
    Mol Genet Metab; 2020 Dec; 131(4):418-423. PubMed ID: 33199206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.